D. Bisset

922 total citations
7 papers, 703 citations indexed

About

D. Bisset is a scholar working on Oncology, Molecular Biology and Dermatology. According to data from OpenAlex, D. Bisset has authored 7 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Dermatology. Recurrent topics in D. Bisset's work include Cancer Treatment and Pharmacology (5 papers), Cancer therapeutics and mechanisms (3 papers) and Chemotherapy-related skin toxicity (3 papers). D. Bisset is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Cancer therapeutics and mechanisms (3 papers) and Chemotherapy-related skin toxicity (3 papers). D. Bisset collaborates with scholars based in United Kingdom, United States and Italy. D. Bisset's co-authors include Frank V. Fossella, Davorin Radosavljević, Marcello Tiseo, Joan H. Schiller, Luca Boni, Paola Mazzanti, Marianne Paesmans, Andrea Ardizzoni, Adriano Paccagnella and Petr Zatloukal and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

In The Last Decade

D. Bisset

7 papers receiving 688 citations

Peers

D. Bisset

ONCOL

PRM

MB

CR

PFM

Felipe Melo Cruz Brazil

Naruo Yoshimura Japan

K. Weigang-Köhler Germany

E. Boven Netherlands

Devron R. Shah United Kingdom

Akihiko Suto Japan

Judit Kralovánszky Hungary

Maura A. Kraynak United States

Leslie E. Martin United States

Luisa Foltran Italy

Felipe Melo Cruz Brazil

D. Bisset

354 ×0.7

ONCOL

279 ×0.7

PRM

122 ×0.8

MB

96 ×1.2

CR

86 ×1.5

PFM

Citations per year, relative to D. Bisset D. Bisset (= 1×) peers Felipe Melo Cruz

Countries citing papers authored by D. Bisset

Since Specialization

Citations

This map shows the geographic impact of D. Bisset's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Bisset with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Bisset more than expected).

Fields of papers citing papers by D. Bisset

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Bisset. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Bisset. The network helps show where D. Bisset may publish in the future.

Co-authorship network of co-authors of D. Bisset

This figure shows the co-authorship network connecting the top 25 collaborators of D. Bisset. A scholar is included among the top collaborators of D. Bisset based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Bisset. D. Bisset is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Ardizzoni, Andrea, Luca Boni, Marcello Tiseo, et al.. (2007). Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis. JNCI Journal of the National Cancer Institute. 99(11). 847–857. 464 indexed citations

2.

Ardizzoni, Andrea, Marcello Tiseo, Luca Boni, et al.. (2006). CISCA (cisplatin vs. carboplatin) meta-analysis: An individual patient data meta-analysis comparing cisplatin versus carboplatin-based chemotherapy in first-line treatment of advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 24(18_suppl). 7011–7011. 46 indexed citations

3.

Gourley, Charlie, James T. Cassidy, Leslie Samuel, et al.. (2004). A phase I study of the trinuclear platinum compound, BBR�3464, in combination with protracted venous infusional 5-fluorouracil in patients with advanced cancer. Cancer Chemotherapy and Pharmacology. 53(2). 95–101. 19 indexed citations

4.

Díaz‐Rubio, Eduardo, T.R. Jeffry Evans, Josep Tabernero, et al.. (2002). Capecitabine (Xeloda®) in combination with oxaliplatin: a phase I, dose-escalation study in patients with advanced or metastatic solid tumors. Annals of Oncology. 13(4). 558–565. 88 indexed citations

5.

Vasey, P., Henri Roché, D. Bisset, et al.. (2002). Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer. British Journal of Cancer. 87(10). 1072–1078. 3 indexed citations

6.

Reif, Stefanie, M. Nicolson, D. Bisset, et al.. (2002). Effect of grapefruit juice intake on etoposide bioavailability. European Journal of Clinical Pharmacology. 58(7). 491–494. 56 indexed citations

7.

Bisset, D., Rodney Judson, & Richard Pazdur. (1996). A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Efficacy in the Management of Metastatic Breast Cancer. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact